“Hello, Sol from SiC.”
“Hello, AEGLESEEKER from RFR.”
“Hello, AEGLESEEKER from RFR.”
October 3, 2026 at 5:00 AM
“Hello, Sol from SiC.”
“Hello, AEGLESEEKER from RFR.”
“Hello, AEGLESEEKER from RFR.”
desperately need a #feeder to take advantage of how zoned out i get farming in w@rfr@me and slip the hose attached to the funnel in their hand, into my mouth
October 3, 2026 at 1:59 AM
desperately need a #feeder to take advantage of how zoned out i get farming in w@rfr@me and slip the hose attached to the funnel in their hand, into my mouth
Queen's University researchers just started testing a patent-pending process on Renforth Resources' Victoria deposit — designed to pull nickel from rock standard processing can't reach.
Issued on behalf of Renforth Resources Inc. (CSE: RFR | OTC: RFHRF)
It also captures CO₂ from air as it works.
Issued on behalf of Renforth Resources Inc. (CSE: RFR | OTC: RFHRF)
It also captures CO₂ from air as it works.
October 2, 2026 at 1:56 PM
Queen's University researchers just started testing a patent-pending process on Renforth Resources' Victoria deposit — designed to pull nickel from rock standard processing can't reach.
Issued on behalf of Renforth Resources Inc. (CSE: RFR | OTC: RFHRF)
It also captures CO₂ from air as it works.
Issued on behalf of Renforth Resources Inc. (CSE: RFR | OTC: RFHRF)
It also captures CO₂ from air as it works.
Jon Watts to direct Star Wars Episode X? A Darth Vader movie starring Hayden Christensen? RFR Patreon supporters are already listening via the ad-free RFR Early Bird but everyone else has to wait until Friday night! Join us! www.patreon.com/RebelForceRa...
Star Wars Episode X Director Revealed | ILM's John Goodson Interview | Rebel Force Radio
Star Wars Episode X Director Revealed | ILM's John Goodson Interview by Rebel Force Radio on Patreon. Join Rebel Force Radio's community for exclusive content and updates.
www.patreon.com
October 2, 2026 at 4:55 AM
Jon Watts to direct Star Wars Episode X? A Darth Vader movie starring Hayden Christensen? RFR Patreon supporters are already listening via the ad-free RFR Early Bird but everyone else has to wait until Friday night! Join us! www.patreon.com/RebelForceRa...
Jon Watts to direct #StarWars Episode X? A Darth Vader movie starring Hayden Christensen? RFR Patreon supporters are already listening via the ad-free RFR Early Bird but everyone else has to wait until Friday night! Join us! www.patreon.com/RebelForceRa... #podcast #starwarspodcast
Star Wars Episode X Director Revealed | ILM's John Goodson Interview | Rebel Force Radio
Star Wars Episode X Director Revealed | ILM's John Goodson Interview by Rebel Force Radio on Patreon. Join Rebel Force Radio's community for exclusive content and updates.
www.patreon.com
October 2, 2026 at 4:51 AM
Jon Watts to direct #StarWars Episode X? A Darth Vader movie starring Hayden Christensen? RFR Patreon supporters are already listening via the ad-free RFR Early Bird but everyone else has to wait until Friday night! Join us! www.patreon.com/RebelForceRa... #podcast #starwarspodcast
Or every ongoing M&A process… how much stupid value and synergies you have to come up with now to fudge away that extra 1% in RFR in just a few months but George says it’s “actually not bad news”!!!
October 1, 2026 at 3:10 PM
Or every ongoing M&A process… how much stupid value and synergies you have to come up with now to fudge away that extra 1% in RFR in just a few months but George says it’s “actually not bad news”!!!
« Le CPO relève que le RFR moyen des 1 % des foyers les plus aisés a augmenté de près de 50 % entre 2017 et 2024, évolution principalement liée à la progression des revenus du capital[…]À l’inverse, les revenus des ménages les plus modestes ont progressé moins vite que les prix[,…] »
September 30, 2026 at 11:22 PM
« Le CPO relève que le RFR moyen des 1 % des foyers les plus aisés a augmenté de près de 50 % entre 2017 et 2024, évolution principalement liée à la progression des revenus du capital[…]À l’inverse, les revenus des ménages les plus modestes ont progressé moins vite que les prix[,…] »
"Momo" from Breath O' Fire 3 saying "Eeeeiiyy" real weird when she does the dragoon jump move that, iirc, was kind of hard or at least highly suboptimal for her to get and they didn't animate any frames for it she just statically translates across the screen
RFR: people reference BoF games sometimes
RFR: people reference BoF games sometimes
September 28, 2026 at 6:48 PM
"Momo" from Breath O' Fire 3 saying "Eeeeiiyy" real weird when she does the dragoon jump move that, iirc, was kind of hard or at least highly suboptimal for her to get and they didn't animate any frames for it she just statically translates across the screen
RFR: people reference BoF games sometimes
RFR: people reference BoF games sometimes
RFR Q&A #313: Star Wars Tech Talk
An overview of George Lucas’ use of familiar real-world tech combined with some well-placed futuristic ideas and fantastical elements sprinkled in.
www.rebelforceradio.com/shows/2026/9...
An overview of George Lucas’ use of familiar real-world tech combined with some well-placed futuristic ideas and fantastical elements sprinkled in.
www.rebelforceradio.com/shows/2026/9...
RFR Q&A #313: Star Wars Tech Talk — Rebel Force Radio: Star Wars Podcast
Arthur C. Clark once said “Any sufficiently advanced technology is indistinguishable from magic.” For RFR V.I.P. Philip Ehlke, this quote helps make sci-fi more approachable. Philip returns to the Q&A...
www.rebelforceradio.com
September 28, 2026 at 6:26 PM
RFR Q&A #313: Star Wars Tech Talk
An overview of George Lucas’ use of familiar real-world tech combined with some well-placed futuristic ideas and fantastical elements sprinkled in.
www.rebelforceradio.com/shows/2026/9...
An overview of George Lucas’ use of familiar real-world tech combined with some well-placed futuristic ideas and fantastical elements sprinkled in.
www.rebelforceradio.com/shows/2026/9...
baseline in MIDAS Total Score were -25.4 (-30.23, -20.48) and -24.4 (-28.29, -20.59).
CONCLUSION: Notable numerical benefit for rimegepant versus placebo was observed at the end of the DBT phase (Week 12) for MSQ RFR domain score. (🧵 7/9)
CONCLUSION: Notable numerical benefit for rimegepant versus placebo was observed at the end of the DBT phase (Week 12) for MSQ RFR domain score. (🧵 7/9)
September 28, 2026 at 9:51 AM
baseline in MIDAS Total Score were -25.4 (-30.23, -20.48) and -24.4 (-28.29, -20.59).
CONCLUSION: Notable numerical benefit for rimegepant versus placebo was observed at the end of the DBT phase (Week 12) for MSQ RFR domain score. (🧵 7/9)
CONCLUSION: Notable numerical benefit for rimegepant versus placebo was observed at the end of the DBT phase (Week 12) for MSQ RFR domain score. (🧵 7/9)
(end of OLE phase, all participants taking open-label rimegepant), for participants originally assigned DBT rimegepant and DBT placebo, respectively, mean (95% CI) improvements from baseline in MSQ RFR score were 32.6 (29.68, 35.42) and 33.2 (30.03, 36.29), and improvements from (🧵 6/9)
September 28, 2026 at 9:51 AM
(end of OLE phase, all participants taking open-label rimegepant), for participants originally assigned DBT rimegepant and DBT placebo, respectively, mean (95% CI) improvements from baseline in MSQ RFR score were 32.6 (29.68, 35.42) and 33.2 (30.03, 36.29), and improvements from (🧵 6/9)
groups, respectively, mean (95% CI) improvements from baseline in MSQ RFR score were 18.6 (16.24, 20.94) and 15.0 (12.60, 17.37), and improvements in MIDAS Total score were -13.0 (-16.57, -9.52) and -12.0 (-15.52, -8.54). At Week 64 (🧵 5/9)
September 28, 2026 at 9:51 AM
groups, respectively, mean (95% CI) improvements from baseline in MSQ RFR score were 18.6 (16.24, 20.94) and 15.0 (12.60, 17.37), and improvements in MIDAS Total score were -13.0 (-16.57, -9.52) and -12.0 (-15.52, -8.54). At Week 64 (🧵 5/9)
took rimegepant 75 mg every other day and additionally on nonscheduled dosing days if needed. Migraine-Specific Quality of Life Questionnaire (MSQ) v.2.1 (including Role Function Restrictive [RFR] domain) and Migraine Disability Assessment Scale (MIDAS) were assessed throughout. (🧵 3/9)
September 28, 2026 at 9:51 AM
took rimegepant 75 mg every other day and additionally on nonscheduled dosing days if needed. Migraine-Specific Quality of Life Questionnaire (MSQ) v.2.1 (including Role Function Restrictive [RFR] domain) and Migraine Disability Assessment Scale (MIDAS) were assessed throughout. (🧵 3/9)
Improvements in Patient-Reported Outcome Measures Through 64 Weeks' Rimegepant Treatment for Migraine: Analysis of a Randomized Controlled Trial with Open-Label Extension
▶️ Read Full Paper
📚 Source: Journal of pain research
👤 Creator: Richard B Lipton et al.
📅 Date: 2026-09-28
#MigrainePapertag/MigrainePaper" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#MigrainePaper #Migr
▶️ Read Full Paper
📚 Source: Journal of pain research
👤 Creator: Richard B Lipton et al.
📅 Date: 2026-09-28
#MigrainePapertag/MigrainePaper" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#MigrainePaper #Migr
Improvements in Patient-Reported Outcome Measures Through 64 Weeks' Rimegepant Treatment for Migraine: Analysis of a Randomized Controlled Trial with Open-Label Extension
CONCLUSION: Notable numerical benefit for rimegepant versus placebo was observed at the end of the DBT phase (Week 12) for MSQ RFR domain score. During open-label treatment with rimegepant, improvements from baseline in MSQ domain scores and MIDAS Total Score were clinically m...
pubmed.ncbi.nlm.nih.gov
September 28, 2026 at 9:51 AM
Improvements in Patient-Reported Outcome Measures Through 64 Weeks' Rimegepant Treatment for Migraine: Analysis of a Randomized Controlled Trial with Open-Label Extension
▶️ Read Full Paper
📚 Source: Journal of pain research
👤 Creator: Richard B Lipton et al.
📅 Date: 2026-09-28
#MigrainePapertag/MigrainePaper" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#MigrainePaper #Migr
▶️ Read Full Paper
📚 Source: Journal of pain research
👤 Creator: Richard B Lipton et al.
📅 Date: 2026-09-28
#MigrainePapertag/MigrainePaper" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#MigrainePaper #Migr
(-28.29, -20.59)였다.
결론: DBT 단계 종료 시점(12주 차)에 MSQ RFR 영역 점수에서 리메게판트가 위약에 비해 유의미한 수치적 이점이 관찰되었다. 리메게판트를 투여받은 공개 라벨 치료 기간 동안, 64주 차에 MSQ 영역 점수 및 MIDAS 총점의 기저치 대비 개선 폭은 임상적으로 유의미한 (🧵 5/6)
결론: DBT 단계 종료 시점(12주 차)에 MSQ RFR 영역 점수에서 리메게판트가 위약에 비해 유의미한 수치적 이점이 관찰되었다. 리메게판트를 투여받은 공개 라벨 치료 기간 동안, 64주 차에 MSQ 영역 점수 및 MIDAS 총점의 기저치 대비 개선 폭은 임상적으로 유의미한 (🧵 5/6)
September 28, 2026 at 9:43 AM
(-28.29, -20.59)였다.
결론: DBT 단계 종료 시점(12주 차)에 MSQ RFR 영역 점수에서 리메게판트가 위약에 비해 유의미한 수치적 이점이 관찰되었다. 리메게판트를 투여받은 공개 라벨 치료 기간 동안, 64주 차에 MSQ 영역 점수 및 MIDAS 총점의 기저치 대비 개선 폭은 임상적으로 유의미한 (🧵 5/6)
결론: DBT 단계 종료 시점(12주 차)에 MSQ RFR 영역 점수에서 리메게판트가 위약에 비해 유의미한 수치적 이점이 관찰되었다. 리메게판트를 투여받은 공개 라벨 치료 기간 동안, 64주 차에 MSQ 영역 점수 및 MIDAS 총점의 기저치 대비 개선 폭은 임상적으로 유의미한 (🧵 5/6)
(-16.57, -9.52)과 -12.0 (-15.52, -8.54)이었습니다. 64주차(OLE 단계 종료 시점, 모든 참가자가 개방형 라임게판트를 복용 중)에, 원래 DBT 라임게판트군과 DBT 위약군에 각각 배정된 참가자들의 경우, MSQ RFR 점수의 기저치 대비 평균(95% 신뢰구간) 개선치는 32.6 (29.68, 35.42) 및 33.2 (30.03, 36.29)였으며, MIDAS 총점의 기저치 대비 개선 폭은 각각 -25.4 (-30.23, -20.48)와 -24.4 (🧵 4/6)
September 28, 2026 at 9:43 AM
(-16.57, -9.52)과 -12.0 (-15.52, -8.54)이었습니다. 64주차(OLE 단계 종료 시점, 모든 참가자가 개방형 라임게판트를 복용 중)에, 원래 DBT 라임게판트군과 DBT 위약군에 각각 배정된 참가자들의 경우, MSQ RFR 점수의 기저치 대비 평균(95% 신뢰구간) 개선치는 32.6 (29.68, 35.42) 및 33.2 (30.03, 36.29)였으며, MIDAS 총점의 기저치 대비 개선 폭은 각각 -25.4 (-30.23, -20.48)와 -24.4 (🧵 4/6)
결과: DBT 단계에서 741명의 참가자(평균 [표준편차] 연령 41.2 [13.06]세, 여성 82.7%)가 연구 약물을 1회 이상 투여받았으며, OLE 단계에서는 603명의 참가자가 리메게판트를 투여받았다. 12주 시점(DBT 단계 종료 시점)에서, 리메게판트군과 위약군의 MSQ RFR 점수 기준선 대비 평균(95% 신뢰구간) 개선 폭은 각각 18.6 (16.24, 20.94) 및 15.0 (12.60, 17.37)였으며, MIDAS 총점의 개선 폭은 각각 -13.0 (🧵 3/6)
September 28, 2026 at 9:43 AM
결과: DBT 단계에서 741명의 참가자(평균 [표준편차] 연령 41.2 [13.06]세, 여성 82.7%)가 연구 약물을 1회 이상 투여받았으며, OLE 단계에서는 603명의 참가자가 리메게판트를 투여받았다. 12주 시점(DBT 단계 종료 시점)에서, 리메게판트군과 위약군의 MSQ RFR 점수 기준선 대비 평균(95% 신뢰구간) 개선 폭은 각각 18.6 (16.24, 20.94) 및 15.0 (12.60, 17.37)였으며, MIDAS 총점의 개선 폭은 각각 -13.0 (🧵 3/6)
52주간의 공개 연장(OLE) 단계 동안 모든 참가자는 격일로 리메게판트 75mg을 복용했으며, 필요한 경우 예정된 투여일이 아닌 날에도 추가로 복용했습니다. 연구 기간 내내 편두통 특이적 삶의 질 설문지(MSQ) v.2.1(역할 기능 제한[RFR] 영역 포함) 및 편두통 장애 평가 척도(MIDAS)를 통해 평가가 이루어졌다. (🧵 2/6)
September 28, 2026 at 9:43 AM
52주간의 공개 연장(OLE) 단계 동안 모든 참가자는 격일로 리메게판트 75mg을 복용했으며, 필요한 경우 예정된 투여일이 아닌 날에도 추가로 복용했습니다. 연구 기간 내내 편두통 특이적 삶의 질 설문지(MSQ) v.2.1(역할 기능 제한[RFR] 영역 포함) 및 편두통 장애 평가 척도(MIDAS)를 통해 평가가 이루어졌다. (🧵 2/6)
6 [PS5] Trails in the Sky 2nd Chapter (NEW)
7 [NSW] Tomodachi Life: Living the Dream (-2)
8 [PS5] Onimusha: Way of the Sword (-5)
9 [NSW] Minecraft (-1)
10 [PS5] NBA 2K27 (-7)
Ranking in units, retail only, no bundle
Source : GFK via RFR
7 [NSW] Tomodachi Life: Living the Dream (-2)
8 [PS5] Onimusha: Way of the Sword (-5)
9 [NSW] Minecraft (-1)
10 [PS5] NBA 2K27 (-7)
Ranking in units, retail only, no bundle
Source : GFK via RFR
🇫🇷 France Charts | Week 37, 2026 (Sep 7 - Sep 13)
1. The Blood of Dawnwalker
2. Onimusha: Way of the Sword
3. NBA 2K27
4. Orbitals
5. Tomodachi Life: Living the Dream
1. The Blood of Dawnwalker
2. Onimusha: Way of the Sword
3. NBA 2K27
4. Orbitals
5. Tomodachi Life: Living the Dream
September 27, 2026 at 5:59 PM
6 [PS5] Trails in the Sky 2nd Chapter (NEW)
7 [NSW] Tomodachi Life: Living the Dream (-2)
8 [PS5] Onimusha: Way of the Sword (-5)
9 [NSW] Minecraft (-1)
10 [PS5] NBA 2K27 (-7)
Ranking in units, retail only, no bundle
Source : GFK via RFR
7 [NSW] Tomodachi Life: Living the Dream (-2)
8 [PS5] Onimusha: Way of the Sword (-5)
9 [NSW] Minecraft (-1)
10 [PS5] NBA 2K27 (-7)
Ranking in units, retail only, no bundle
Source : GFK via RFR
Traveling soon? Check out Welcome Pickups - a personalised transfer service designed for travel. Use this link to get €5 off your first ride! welc.io/rfr/VWEoERG3...
Welcomepickups
welc.io
September 27, 2026 at 11:31 AM
Traveling soon? Check out Welcome Pickups - a personalised transfer service designed for travel. Use this link to get €5 off your first ride! welc.io/rfr/VWEoERG3...
サーモス 保冷ランチバッグ 7L コダック ブルーグレー RFR-007PK(ポケモンシリーズ) BGY の、Amazonでの販売再開の監視を終了しました。
サーモス 保冷ランチバッグ 7L コダック ブルーグレー RFR-007PK（ポケモンシリーズ) BGY
サーモス(THERMOS) 2026/8/21(金)発売
5leaf.jp
September 27, 2026 at 2:33 AM
サーモス 保冷ランチバッグ 7L コダック ブルーグレー RFR-007PK(ポケモンシリーズ) BGY の、Amazonでの販売再開の監視を終了しました。
Thanks Feedspot for placing RFR at the top of their current "100 Best Star Wars Podcasts" list. The Force is strong with Feedspot! podcast.feedspot.com/star_wars_po...
100 Best Star Wars Podcasts to Listen to in 2026
Best Star Wars Podcasts to Listen to ⋅ 1. Rebel Force Radio: Star Wars Podcast ⋅ 2. Children of the Watch: A Star Wars After Show ⋅ 3. Marvel Star Wars Explorers
podcast.feedspot.com
September 26, 2026 at 11:50 PM
Thanks Feedspot for placing RFR at the top of their current "100 Best Star Wars Podcasts" list. The Force is strong with Feedspot! podcast.feedspot.com/star_wars_po...
As heard on the latest RFR, after being disappointed with The Last Jedi, writer Alan Dean Foster wrote a treatment for Star Wars: Episode IX. Titled Star Wars: Resurgence and written just for fun, this is how Alan envisioned the sequel trilogy concluding
www.rebelforceradio.com/news/2026/9/...
www.rebelforceradio.com/news/2026/9/...
Alan Dean Foster's Star Wars: Episode IX Treatment — Rebel Force Radio: Star Wars Podcast
Written just for fun, this is how Alan envisioned the sequel trilogy concluding
www.rebelforceradio.com
September 26, 2026 at 8:00 PM
As heard on the latest RFR, after being disappointed with The Last Jedi, writer Alan Dean Foster wrote a treatment for Star Wars: Episode IX. Titled Star Wars: Resurgence and written just for fun, this is how Alan envisioned the sequel trilogy concluding
www.rebelforceradio.com/news/2026/9/...
www.rebelforceradio.com/news/2026/9/...
